Collagenolytic Activity and its Sensitivity to Doxycycline Inhibition in Tracheal Aspirates of Horses with Chronic Obstructive Pulmonary Disease

Acta Veterinaria Scandinavica

Volumn 38, Issue 1, 1997, Pages 9-16

  Koivunen, A L ^a   Maisi, P ^a   Konttinen, Y T ^b   Prikk, K ^b   Sandholm, M ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

activity; COPD; equine; lung; metalloproteinase; MMP; proteinase; proteolysis; tetracycline

Indexed keywords

COLLAGEN; COLLAGENASE; DOXYCYCLINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG ANTAGONISM; ENZYMOLOGY; HORSE; HORSE DISEASE; ISOLATION AND PURIFICATION; METABOLISM; MUCOSA; POLYACRYLAMIDE GEL ELECTROPHORESIS; SUCTION; TRACHEA;

ANIMALS; COLLAGEN; COLLAGENASES; DOXYCYCLINE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HORSE DISEASES; HORSES; LUNG DISEASES, OBSTRUCTIVE; MUCOUS MEMBRANE; SUCTION; TRACHEA;

EID: 0030631813     PISSN: 0044605X     EISSN: 17510147     Source Type: Journal    
DOI: 10.1186/BF03548503     Document Type: Article

References (30)

1. Campbell EJ, Senior RM, Welgus HG: Extracellular matrix injury during lung inflammation. Chest 1987, 92, 161–167. DOI: 10.1378/chest.92.1.161
2. Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Libby B: Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions. Ann. N. Y. Acad. Sci. 1995, 748, 501–507. DOI: 10.1111/j.1749-6632.1994.tb17348.x
3. Goldberg GI, Wilhelm SM, Kronberger A, Bauer EA, Grant GA, Eisen AZ: Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein. J. Biol. Chem. 1986, 261, 6600–6605.
4. Golub LM, McNamara TF, D‘Angelo G, Greenwald RA, Ramamurthy NS: A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity. J. Dent. Res. 1987, 66, 1310–1314. DOI: 10.1177/00220345870660080401
5. Golub LM, Ramamurthy NS, McNamara TF, Greenwald RA, Rifkin BR: Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. Crit. Rev. Oral Biol. Med. 1991, 2, 297–321. DOI: 10.1177/10454411910020030201
6. Golub LM, Suomalainen K, Sorsa T: Host modulation with tetracyclines and their chemically modified analogues. Curr. Opi. Dent. 1992, 2, 80–90.
7. Grant GA, Goldberg GI, Wilhelm SM, He C, Eisen AZ: Activation of extracellular matrix metalloproteases by proteases and organomercurials. Matrix 1992, Suppl. 1, 217–223.
8. Grunig G, Hermann M, Von Fellenberg R: Protease and antiprotease activity in the respiratory secre- tions of horses suffering from COPD. In: Deegen E., Beadle RE, (ed.). Lung function and respiratory diseases in the horse. International Symposium in Hannover, Germany, June 27-29, 1985, Hippiatrica, Stuttgart, Germany, pp. 29–31.
9. Guttmann I, Bergmayer HU: Determination of urea with glutamate dehydrogenase as indicator enzyme. In: Bergmayer, HU. (ed.): Methods of enzymatic analysis. 2nd ed. Academic Press, New York. 1974, pp. 1794–1798.
10. Koivunen A-L, Maisi P, Fang W, Sandholm M: Inhibition of the protease activity in tracheobronchial aspirates of horses with chronic obstructive pulmonary disease. Amer. J. vet. Res. 1996, 57, 603–607.
11. Koivunen A-L, Maisi P, Konttinen YT, Sandholm M: Gelatinolytic activity in tracheal aspirates of horses with chronic obstructive pulmonary disease. Acta vet. scand. 1997, 17–27.
12. Konttinen YT, Kangaspunta P, Lindy O, Takagi M, Sorsa T, Segerberg M, Eisen AZ, Tschesche H: Collagenase in Sjogren’s syndrome. Ann. Rheum. Dis. 1994, 53, 836–839. DOI: 10.1136/ard.53.12.836
13. Lauhio A, Konttinen YT, Tschesche H, Nordstrom D, Salo T, Lahdevirta J, Golub LM, Sorsa T: Reduction of matrix metalloproteinase 8 -neutrophil collagenase levels during long-term doxycycline treatment reactive arthritis. Antimicrob. Agents Chemother. 1994, 38, 400–402. DOI: 10.1128/AAC.38.2.400
14. Lauhio A, Sorsa T, Lindy O, Suomalainen K, Saari H, Golub LM, Konttinen YT: The anticollagenolytic potential of lymecycline in long-term treatment of reactive arthritis. Arthritis Rheum. 1992, 35, 195–198. DOI: 10.1002/art.1780350211
15. MacNamara B, Bauer S, Lafe J: Endoscopic evaluation of exercise-induced pulmonary haemorrhage and chronic obstructive pulmonary disease in association with poor performance in racing Stan- dardbreds. J. Amer. vet. med. Assoc. 1990, 196, 443–445.
16. Mainardi CL, Pourmotabbed TF, Hasty KA: Inflammatory phagocytes and connective tissue degrading metalloproteinases. Amer. J. med. Sci. 1991, 302, 171–175. DOI: 10.1097/00000441-199109000-00010
17. Miller EJ, Rhodes KR: Preparation and characterization of the different Types of collagen. In: Cuningham LW, Fredriksen DW (eds.): Structural and contractile proteins, part A: Methods in enzymology. New York: Academic Press, 1982.
18. Moscatelli D, Rifkin DB: Membrane and matrix localization of proteinases: A common theme in tumour cell invasion and angiogenesis. Biochem. Biophys. Acta 1988, 948, 67–85.
19. Rennard SSI, Basset G, Lecossier D, Donnel KM, Pinkston P, Martin P, Crystal RG: Estimation of volume of epithelial lining fluid recovered by lavage by using urea as a marker of dilution. J. Appl. Physiol. 1986, 60, 532–538. DOI: 10.1152/jappl.1986.60.2.532
20. Rossdale PD, Hopes R, Digby NJ, Offord K: Epidemiological study of wastage among racehorses 1982 and 1983. Vet. Rec. 1985, 116, 66–69. DOI: 10.1136/vr.116.3.66
21. Saari H, Suomalainen K, Lindy O, Konttinen YT, Sorsa T: Activation of latent human neutrophil collagenase by reactive oxygen species and serine proteinases. Biochem. Biophys. Res. Com- mun. 1990, 171, 979–987. DOI: 10.1016/0006-291X(90)90780-Q
22. Sepper RY, Konttinen YT, Ding Y, Takagi M, Sorsa T: Human neutrophil collagenase (MMP-8), identified in bronchiectasis BAL fluid, correlates with severity of disease. Chest 1995, 107, 1641–1647. DOI: 10.1378/chest.107.6.1641
23. Shapiro SD, Campbell EJ, Senior RM, Welgus HG: Proteinases secreted by human mononuclear phagocytes. J. Rheumatol. 1991, (Suppl. 27) 18, 95-98.
24. Sorsa T, Ingman T, Suomalainen K, Haapasalo M, Konttinen YT, Lindy O, Saari H, Uitto V-J: Identification of proteinases from periodontopatho- genic bacteria as activators of latent human neutrophil and fibroblast-Type interstitial collagenases. Infect. Immun. 1992, 60, 4491–4495. DOI: 10.1128/IAI.60.11.4491-4495.1992
25. Sorsa T, Lindy O, Konttinen YT, Suomalainen K, Ingman T, Saari H, Halinen S, Lee H-M, Golub LM, Hall J, Simon S: Doxycycline in the protection of serum alpha-1-antitrypsin from human neutrophil collagenase and gelatinase. Antimicrob. Agents Chemother. 1993, 37, 592–594. DOI: 10.1128/AAC.37.3.592
26. Suomalainen K, Sorsa T, Golub LM, Ramamurthy N, Lee H-M, Uitto V-J, Saari H, Konttinen YT: Specificity of the anti-collagenase action of tetracyclines: relevance to their anti-inflammatory potential. Antimicrob. Agents Chemother. 1992, 36, 227–229. DOI: 10.1128/AAC.36.1.227
27. Turto H, Lindy S, Uitto V-J, Wegelius O, Uitto J: Human leukocyte collagenase: characterization of enzyme kinetics by a new method. Anal. Biochem. 1977, 83, 557–569. DOI: 10.1016/0003-2697(77)90059-8
28. Weiss SJ: Tissue destruction by neutrophils. N. Engl. J. Med. 1989, 320, 365–376.
29. Werb Z, Gordon S: Secretion of a specific collagenase by stimulated macrophages. J. Exp. Med. 1975, 142, 346–360. DOI: 10.1084/jem.142.2.346
30. Woessner JF: Matrix metalloproteinases and their inhibitors in connective tissue remodelling. FASEB J. 1991, 5, 2145–2154. DOI: 10.1096/fasebj.5.8.1850705